DeliriumNu-DESC DKNCT02628925
Nu-DESC DK: The Danish Version of the Nursing Delirium Screening Scale
An observational study of Delirium, run by Naestved Hospital.
Trial summary
Delirium is one of the most common complications among elderly hospitalized patients, postoperative patients and patients on intensive care units. The reported prevalence is between 11 and 80 %. Delirium is associated with a high morbidity and threefold higher 6-month mortality. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Delirium
- What is being tested?
- Nu-DESC DK
- Type of treatment
- Medical device
- How many people
- 20 participants
- Where
- No sites listed yet
- Study dates
- Sep 2014to Apr 2015
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: Medical staff on 2 different wards
Who may be able to join
- Medical staff working in the recovery room or orthopedic ward
Who cannot join
- Medical staff from other wards
About this study
Official title: Nu-DESC DK: The Danish Version of the Nursing Delirium Screening Scale (Nu-DESC DK)
Delirium is one of the most common complications among elderly hospitalized patients, postoperative patients and patients on intensive care units. The reported prevalence is between 11 and 80 %. Delirium is associated with a high morbidity and threefold higher 6-month mortality. The Nursing-Delirium Screening Scale (Nu-DESC) is a screening tool with a high sensitivity and specificity.
The purpose of this study is to translate the Nu-DESC to danish and evaluate afterwards its feasibility and understanding by different medical staff.
Read more
Material and methods:
The Nu-DESC will be translated after International Society for Pharmacoeconomics and Outcomes Research (ISPOR) guidelines to Danish by permission of the original author.
The evaluation will be performed, by filling out evaluation forms, where the feasibility and understanding will be rated on a 6 step Likert scale.
Read the detailed description
Translation of the original tool and evaluation of understanding and feasibility by medical staff.
- Conditions
- Delirium
- Being tested
- Nu-DESC DK
- Keywords
- mass screening, Nursing diagnosis, Psychiatric Status Rating Scale
- Medical subject headings
- Delirium
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Nu-DESC DKDevice
Nu-DESC DK as a screening tool is presented to the medical staff and they have to evaluate the tool an evaluate the screening tool on a evaluation form and rates on a 6 step Likert scale.
| Study group | Role | What they receive |
|---|---|---|
| Recovery room | 10 medical staff working in the recovery room Receives: Device: Nu-DESC DK | |
| Orthopedic ward | 10 medical staff working on the orthopedic ward Receives: Device: Nu-DESC DK |
What is being measured
The primary outcome is the main question the study is designed to answer.
Difference in understanding of the content of Nu-DESC DK by different medical staff groups
All five sections of Nu-DESC DK will each be rated on a 6 step Likert scale regarding language and content.
Measured: Within the first week after questionnaire is filled out
Difference in feasibility of the content of Nu-DESC DK by different medical staff groups
All five sections of Nu-DESC DK will each be rated on a 6 step Likert scale regarding time and usability
Measured: Within the first week after questionnaire is filled out
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Dec 2015 (estimated)
- Study startSep 2014
- Primary completionFeb 2015
- Study completionApr 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DeliriumStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- Naestved Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02628925
- Sponsor's protocol ID
- DHAG-001-2014
- Acronym
- Nu-DESC DK
- Status last verified
- Dec 2015
- First submitted
- 27 Nov 2015
- Last updated
- 11 Dec 2015
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 11 Dec 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Nu-DESC DK: The Danish Version of the Nursing Delirium Screening Scale (Nu-DESC DK)
- ClinicalTrials.gov ID
- NCT02628925
- Acronym / sponsor ID
- Nu-DESC DK / DHAG-001-2014
- Conditions
- Delirium
- Keywords
- mass screening, Nursing diagnosis, Psychiatric Status Rating Scale
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- Naestved HospitalUniversity, hospital or other
- Study start
- Sep 2014
- Primary completion
- Feb 2015 (actual)
- Study completion
- Apr 2015 (actual)
- First posted
- 11 Dec 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Delirium is one of the most common complications among elderly hospitalized patients, postoperative patients and patients on intensive care units. The reported prevalence is between 11 and 80 %. Delirium is associated with a high morbidity and threefold higher 6-month mortality. The Nursing-Delirium Screening Scale (Nu-DESC) is a screening tool with a high sensitivity and specificity.
The purpose of this study is to translate the Nu-DESC to danish and evaluate afterwards its feasibility and understanding by different medical staff.
Material and methods:
The Nu-DESC will be translated after International Society for Pharmacoeconomics and Outcomes Research (ISPOR) guidelines to Danish by permission of the original author.
The evaluation will be performed, by filling out evaluation forms, where the feasibility and understanding will be rated on a 6 step Likert scale.
Detailed description
Translation of the original tool and evaluation of understanding and feasibility by medical staff.
Study design
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Recovery room | – | Device: Nu-DESC DK10 medical staff working in the recovery room |
| Orthopedic ward | – | Device: Nu-DESC DK10 medical staff working on the orthopedic ward |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Medical staff on 2 different wards
Key inclusion criteria (1 listed)
- Medical staff working in the recovery room or orthopedic ward
Key exclusion criteria (1 listed)
- Medical staff from other wards
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Nu-DESC DKNu-DESC DK as a screening tool is presented to the medical staff and they have to evaluate the tool an evaluate the screening tool on a evaluation form and rates on a 6 step Likert scale. | Device | Orthopedic ward, Recovery room |
Primary outcome
Difference in understanding of the content of Nu-DESC DK by different medical staff groups
Time frame: Within the first week after questionnaire is filled out
All five sections of Nu-DESC DK will each be rated on a 6 step Likert scale regarding language and content.
Difference in feasibility of the content of Nu-DESC DK by different medical staff groups
Time frame: Within the first week after questionnaire is filled out
All five sections of Nu-DESC DK will each be rated on a 6 step Likert scale regarding time and usability
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Dec 2015.
Related trials for Delirium
RecruitingObservational study
The Impact of Fast-Track Anesthesia on Postoperative Neurocognitive Function in Patients Undergoing Cardiac Surgery
Delirium - Postoperative, Cardiac Surgery
Not yet recruiting
Prediction and Prevention of Postoperative Mortality and Morbidity
Dementia, Postoperative Delirium (POD)
Active, not recruitingPhase 3
The Danish Out-of-Hospital Cardiac Arrest Study
Out-Of-Hospital Cardiac Arrest, Post-Cardiac Arrest Syndrome
RecruitingPhase 3
Lactium Premedication to Prevent Emergence Agitation
Lactium, Premedication
Not yet recruiting
DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial)
Neurosurgery, Brain Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Delirium, run by Naestved Hospital.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 11 Dec 2015. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Difference in understanding of the content of Nu-DESC DK by different medical staff groups (time frame: Within the first week after questionnaire is filled out). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Dec 2015.